China Pharma Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Net Income	-3.08	-3.97	-3.4	-2.87	-20.7	-10.75	-19.28	-9.18	-15.41	-39.55	Upgrade
Depreciation & Amortization	2.75	2.7	3.09	2.68	2.93	3.26	3.29	3.08	3.6	1.79	Upgrade
Share-Based Compensation	0	0.08	0.02	0	0	0	0	0	0	0	Upgrade
Other Operating Activities	-0.37	0.78	0.05	0.15	18.38	9.37	16.83	9	15.16	43.92	Upgrade
Operating Cash Flow	-0.7	-0.41	-0.25	-0.04	0.61	1.88	0.84	2.9	3.35	6.15	Upgrade
Operating Cash Flow Growth	-	-	-	-	-67.68%	123.74%	-70.95%	-13.56%	-45.55%	-28.42%	Upgrade
Capital Expenditures	-0.01	-0.4	-0.44	-0.87	-0.14	-0.05	-0.14	-0.19	-0.69	-5.13	Upgrade
Change in Investments	0	0	0	0	0	0	0	0	0.42	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	-1.63	-2.3	Upgrade
Investing Cash Flow	-0.01	-0.4	-0.44	-0.87	-0.14	-0.05	-0.14	-0.19	-1.9	-7.42	Upgrade
Debt Issued / Paid	0.07	-1.77	4.6	0.62	-1.73	-1.98	-1.48	-6.02	0	0.61	Upgrade
Financing Cash Flow	0.07	-1.77	4.6	0.62	-1.73	-1.98	-1.48	-6.02	0	0.61	Upgrade
Exchange Rate Effect	0.03	-0.25	-0.01	0.06	-0.02	-0.13	0.14	-0.26	-0.5	-0.03	Upgrade
Net Cash Flow	-0.61	-2.83	3.9	-0.23	-1.28	-0.28	-0.64	-3.58	0.95	-0.7	Upgrade
Free Cash Flow	-0.71	-0.81	-0.69	-0.91	0.47	1.83	0.7	2.7	2.66	1.02	Upgrade
Free Cash Flow Growth	-	-	-	-	-74.20%	159.81%	-73.92%	1.41%	160.16%	-	Upgrade
Free Cash Flow Margin	-10.14%	-10.01%	-7.13%	-8.37%	4.32%	14.85%	5.33%	17.36%	13.09%	4.63%	Upgrade
Free Cash Flow Per Share	-0.21	-0.77	-0.75	-1.04	0.54	2.10	0.81	3.10	3.06	1.18	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).